Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician's office.
Promaxo has raised $26.8M in total funding. The most recent round was Series Unknown. The last funding was announced in March 2026.
Promaxo's investors include Kineticos Disruptor Fund, Huami, Zynext Ventures, Fred Moll, M.D, MicroPort Scientific.
Promaxo is headquartered in Oakland, United States.
Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician's office.
Promaxo is at the Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Promaxo — Funding & Investors." VCBacked, March 30, 2026, https://www.vcbacked.co/company/promaxo. Accessed August 14, 2026.
VCBacked. (2026). Promaxo — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/promaxo
{{cite web |title=Promaxo — Funding & Investors |url=https://www.vcbacked.co/company/promaxo |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated